Resources

The latest in formulation & delivery research, from discovery and multi-omics approaches through to diagnostics development

Drug Delivery

Novel Nanorobots Pave the Way for Cancer Treatment

A preclinical study conducted by a team of scientists at the Institute for Bioengineering of Catalonia highlights the therapeutic potential of nanorobots in bladder cancer treatment.
Drug Delivery

Sangamo Therapeutics Engineers a State-Of-The-Art Capsid, Revolutionising Drug Delivery

Sangamo Therapeutics developed a novel capsid that achieved outstanding results in a preclinical study, this could have significant implications for treating neurological disorders.
RNA Formulation & Delivery

Reimagining Cystic Fibrosis Treatment With RNA Therapeutics

A preclinical study conducted by a group of researchers at the University of Pennsylvania shows promise in treating cystic fibrosis using RNA therapeutics.
RNA Formulation & Delivery

RNA beyond the liver: challenges in non-liver rna therapeutic delivery

Advancements in RNA therapeutic delivery are extending beyond liver-specific treatments, addressing complex challenges and enabling broader applications in medicine. Innovations in lipid nanoparticles, RNA interference, and artificial intelligence are key to this progress, offering potential treatments for a range of diseases and moving closer to personalized medicine. Despite remaining challenges, these developments mark significant strides towards transformative patient care.
Inhaled Drug Delivery

Beyond the Needle: Exploring the Potential of an Inhaled TB Vaccine

Research efforts aim to investigate whether an inhaled version of the tuberculosis (TB) vaccine, Bacille Calmette-Guérin (BCG) is more effective than the traditional intradermal method of delivery.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Inhaled Drug Delivery

Advancements in Inhaled Gene Therapy for Pulmonary Conditions

Delve into the specifics of inhaled gene therapy, its mechanisms, applications, and future prospects, it's essential to appreciate the foundational principles of gene therapy that paved the way for these advancements.
Drug Delivery

Next-Generation Cancer Treatment Shows Promising Results: CRB-701 Hits Milestones in First-In-Human Study

With ongoing dose escalation and expansion, CRB-701 holds promise as a next-generation treatment for patients battling advanced cancers.
Drug Formulation

The Roadmap of ADC Formulation & Delivery: Achievements and Obstacles

Dive into the progress and challenges in Antibody-Drug Conjugates formulation and delivery for cancer treatment. We emphasize the advancements in targeting precision and efficacy, while discussing key development challenges like target selection, drug potency, and manufacturing complexities in this evolving oncology field.
Inhaled Drug Delivery

Toward the Next Generation of Sustainable Inhalers

Millions use inhalers to treat pulmonary conditions in the UK. What is their environmental impact, and how can they be improved for a sustainable future?
Inhaled Drug Delivery

Breathing New Life into Treatment: The Revolutionary Promise of Inhaled Drug Delivery

Explore the groundbreaking advancements in inhaled drug delivery, a transformative approach that promises enhanced efficacy and patient convenience
Drug Delivery

Bath University Develops Microneedle Skin Patch for Painless Drug Delivery

The microneedle drug delivery skin patch is made of hydrogel, making it cheap and sustainable to produce.
Drug Delivery

Serina Therapeutics Licences Small Molecule Continuous Delivery Technology to Pfizer

Serina Therapeutics licences their continuous drug delivery platform to Pfizer, which includes lipid nanoparticle delivery systems.
Drug Delivery

Exploring the Pinnacle of Pharmaceutical Innovation: Latest Advancements in Small Molecule Drug Formulation

Advancements in Small Molecule Drug Formulation has witnessed remarkable progress in recent years including nanotechnology and new improved drug delivery systems.
Drug Formulation

Kurma Partners to Collaborate with Samsung Biologics for the Development and Manufacture of Biologics Drugs

Samsung Biologics will develop and manufacture drugs for Kurma’s portfolio companies, including by providing CMC drug development.
Drug Formulation

Interviewing Rishabh Tukra, Process Development Senior Scientist at Amgen

Before joining Amgen, Dr Tukra got his PhD from Purdue University in Industrial and Physical Pharmacy. While at Purdue he also worked at LyoHUB as an advisor and researcher in industrial and academic projects.
Drug Formulation

Achieving Faster Formulation of Solid Oral Dosage Forms for First-in-human Supplies Using Drug-in-capsule Approach

The pharmaceutical industry is increasingly looking for approaches to shorten drug development timelines and save on cost, especially virtual biotech companies who rely heavily on key milestone payments. It is therefore imperative that new chemical entities can be quickly manufactured quickly into clinical drug products.
Drug Formulation

Almac Pharma Services

Tailor-made pharmaceutical development & commercial solutions.
Drug Formulation

Almac: Paediatric Drug Product Development Through to Commercialisation

How Almac developed a flexible paediatric dosage form using a robust manufacturing and filling process suitable for routine commercial manufacture.
Drug Formulation

Almac: Pharmaceutical Development

Specialising in solid oral dose formulations, 300,000ft² of drug product development footprint, multiple containment strategies for highly potent materials.
Drug Formulation

Aptar Pharma: Reliable Development, Reliable Effect

Aptar Pharma’s range of UDS (Unidose system) systems, particularly the UDS powder, is a proven, ready-to-use platform, providing a precise single dose via the nose quickly and easily.
Drug Formulation

Cell and Gene Therapies Analytical Development Services

CMC development support, characterisation, stability and quality control services.
Drug Formulation

Inhaled & Intranasal Biologic Drug Development

Contract drug development expertise to accelerate your inhaled biomolecule to market.
Drug Formulation

Intertek Biopharmaceutical Services

To meet your development milestones and comply with regulatory requirements, you will need high quality bioanalytical and analytical data to aid informed decision-making and identify sources of risk.
Drug Formulation

Intertek: GMP & CMC Laboratory Services

Stability programs are a fundamental component of pharmaceutical product development, playing an essential role across the lifecycle of pharmaceutical products.
Drug Formulation

Intertek: Support for Small & Large Molecules Across All Respiratory Delivery Technology Platforms

30+ years of experience inhaled and nasal product development.
Drug Formulation

mRNA Vaccine and Therapeutic Products Analytical Development Services

CMC development support, characterisation, stability, and quality control services.
Drug Formulation

Orally Inhaled and Nasal Drug Product (OINDP) Development and Testing

Support for Metered Dose Inhalers, Dry Powder Inhalers (DPIs), Nasal sprays and other classes of OINDP.
Drug Formulation

Pharmaceutical Bioanalysis Services

Bioanalytical Expertise from Preclinical to Commercialisation
Drug Formulation

Pharmaceutical Services Laboratory & Assurance Solutions

Across your product lifecycle, our expertise brings you the insight you need to accelerate pharmaceutical, biopharmaceutical or medical device product development.
Drug Formulation

The Experic Difference for Analytical Services

Experic’s analytical services provide powerful support at every phase of pharmaceutical development and manufacturing.
Drug Formulation

The Experic Difference for Customized Particle Engineering

Solve Development Scale Powder Challenges with Spray Drying Technology. Control Particle Size and Morphology and Enhance Solubility and Bioavailability with Spray Dried Dispersions.
Drug Formulation

The Experic Difference for Dry Powder Inhalation

When you need customized and scalable filling, packaging and logistics solutions for reservoir and single-dose dry powder inhalation (DPI) devices, Experic offers an experienced team and state-of-the-art capabilities.
Drug Formulation

Toward Sustainable Packaging Solutions for Drug Manufacturers

In the quest for sustainable packaging solutions in the pharmaceutical industry, drug manufacturers are grappling with the need to reduce waste while maintaining the stringent requirements for medicine packaging.
Drug Formulation

Sustainable Drug Formulation: Paving the Path for Greener Pharmaceutical Future

What are the top eco-friendly drug formulation techniques in green pharma? Explore the intersection of pharmaceuticals and sustainability. Dive into sustainable drug formulation, understand its environmental implications, and discover how the industry is innovating for a greener future.

ChemGenes Corporation is now ISO 9001:2008 Certified Company

Since 1981, the products and services provided by ChemGenes Corporation continue to accelerate the pace of DNA/RNA oligonucleotide synthesis, research, and development in the pharmaceutical and biotechnology industry.
RNA Formulation & Delivery

Fast-track Your Omics Data Analysis

From weeks to minutes with Omics Playground
RNA Formulation & Delivery

Solving Nanotechnology Application Challenges

Industry-leading Microfluidizer® processor technology for optimum performance and superior product quality.

Navigating the Pharma R&D Regulatory Landscape 2023

Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Drug Formulation

What is Spray Freeze Drying?

Unlocking the potential of spray freeze drying: Challenges and strategies for commercialization
Drug Formulation

New Freeze-Drying Technologies: Pfizer's Quest for Sustainable Cooling

Pfizer continues to explore even greener alternatives to traditional lyophilisation methods like air cooling in its pursuit of environmental sustainability.
Drug Formulation

Vanguard Strategies: Perspectives on Developing Novel Pharma Technologies

Novel technologies in drug development, including personalized medicine manufacturing, cyclic peptides, and continuous manufacturing methods.
Inhaled Drug Delivery

Why Inhalation Products Benefit from Patient-Centric Design

Inhalation products provide a patient-centric approach to delivering therapeutics directly to the lungs: with an estimated 800 million people suffering from chronic respiratory diseases worldwide, major potential for greater utility exists.
Drug Formulation

TC1 Bacterium Identified by GSK Could be Key to Controlling the Spread of Malaria

Researchers from GSK and John Hopkins University have discovered a strain of bacteria which can lower the amount of malaria carried by mosquitoes.
Drug Formulation

New HIV Drug Formulation Breakthrough for Paediatric Applications

While anti-retroviral therapies (ARTs) have transformed HIV from a death sentence into a manageable condition, paediatric applications of these therapies have remained limited.
Drug Formulation

Navigating the Drug Development Pipeline from Discovery to Product

If developers maintain a holistic plan for the entirety of the developmental process it increases the likelihood of a drug’s successful discovery.
Drug Delivery

The Utility of Nanoparticles in Tissue-Targeted Drug Delivery

Nanoparticles play a crucial role in tissue-targeted drug delivery, enabling the concentration of therapeutic agents at specific sites while minimising off-target events. Here, we explore some of their potential applications in drugging bone marrow and brain tissue.
RNA Formulation & Delivery

The Woman Who Changed the Course of the Pandemic: Katalin Karikó and the mRNA Revolution

Karikó's efforts and dedication have had a profound impact on the world, allowing us to navigate the pandemic with the help of mRNA vaccines.
Drug Delivery

Novel Delivery Systems: Oral Films for Patient-Centric Care

The team is now working on commercializing the technology through their start-up PharLyfe+.
Drug Formulation

The Discovery of Pancreatic Diabetes and Insulin Development

The discovery and isolation of insulin in 1921 revolutionised the treatment of diabetes, which previously had no real preventative approach. Researchers found that the pancreas plays a crucial role in regulating blood sugar levels, leading to the development of insulin.
RNA Formulation & Delivery

Fast-track Your Omics Data Analysis

From weeks to minutes with Omics Playground
RNA Formulation & Delivery

Solving Nanotechnology Application Challenges

Industry-leading Microfluidizer® processor technology for optimum performance and superior product quality
Drug Delivery

Nanoscale 3D Printing Unleashed: The Path to Personalized Medicine and 4D Innovation

The sintering process in nanoscale 3D printing has paved the way for 4D printing, allowing devices printed in 3D to undergo transformational deformation in response to stimuli.
Drug Formulation

The Untapped Potential of India’s Top CROs and CDMOs

Here, we look at the growing importance of India’s biotech companies, and the scope for collaboration with international pharmaceutical companies, with high-quality contract research organisations (CROs) capable of conducting diverse research projects.
Drug Delivery

Rani Strengthens Partnership with Celltrion to Develop Adalimumab (Humira) Biosimilar

The collaboration will focus on RT-105, an orally administered biosimilar for adalimumab, an anti-inflammatory monoclonal antibody used to treat autoimmune diseases.
Drug Delivery

Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

Celanese to Supply VitalDose® Drug Delivery Platform for Glaukos’ Investigational iDose® TR Intraocular Implant.
Drug Formulation

Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments

VitalDose® EVA drug delivery platform to be used in the development of Alessa Therapeutics’ proprietary localized drug delivery technology.
Drug Delivery

Harro Hofliger: Company Portfolio

Extensive experience with processes in sterile conditions.
Drug Formulation

Advanced Formulation Development Strategies & Towards Sustainable Lyophilisation

Optimising drug delivery, stability, and patient outcomes through considerations such as formulation simplicity, critical temperatures, excipient selection, and the use of digital approaches.
Drug Formulation

BioDur-Sundia: Moving You Forward

End-to-End Solutions: Integrated Services to Navigate your BEST Path to Market
Drug Formulation

Development and Clinical Trial Material Manufacturing

BioDuro-Sundia’s Pharmaceutics team is well versed in turning challenging molecules to dosage forms ready for clinical trial in an efficient, reliable, and timely manner.
Drug Formulation

Solution Engine 2.0: Rapid Formulation Development of Amorphous Solid Dispersions by Combined In-Silico Modelling, High-Throughput Screening and in-vivo PK Study

Amorphous solid dispersion (ASD) technology has been successfully utilized to enhance solubility and bioavailability of poorly soluble APIs.
Drug Formulation

Globalizing Drug Development Programs for FDA Approval

Studies with a higher degree of representation will indicate patient populations that exhibit greater responsiveness to treatment, with global drug development programs integral to the safe development of future therapeutics.
Inhaled Drug Delivery

Sir David Jack: a Titan of Inhaled Medicine

One of the pioneers of inhaled therapies, David Jack discovered countless drugs to treat asthma and similar conditions.
RNA Formulation & Delivery

Overcoming Challenges in Formulating and Delivering RNA Therapeutics: Insights from Formulation & Delivery US

What needs to be considered for RNA drug delivery? From the stability of LNPs, to proteins in the blood, to descant selection and packaging.
Drug Formulation

Collaborative Drug Design Strategies for Broadening Approaches to Formulation and Delivery

Although the past three decades have seen significant increases in the cost and time associated with delivering new drugs for clinical use, efforts to increase the number of molecules arriving through the drug development pipeline have been underwhelming. But what if the solution has been hiding in plain sight?
Drug Delivery

Machine Learning Methods in Drug Delivery: Three Approaches to Watch

New approaches to accelerating and refining the development of therapeutics are constantly being trialled across the globe. Here, we explore three different ways in which machine learning is being integrated into drug delivery and development.
Drug Formulation

Merck and XtalPi Collab for Computational Drug Development Techniques

The study highlighted the benefits of combining computational workflows with experimental validation for the rational engineering of desirable crystal habits, demonstrating how the collaboration is transforming pharmaceutical development and positively impacting patients' lives.
RNA Formulation & Delivery

Spotlight on mRNA Vaccines: Made But Not Defined by the Pandemic

Where is the formulation and delivery of mRNA vaccines heading in the years after the pandemic?
Drug Formulation

Blockbuster Drugs and Applications of AI in Accelerating the R&D Timeline for Drug Development

The future of AI in drug discovery and development looks promising. However, pharma’s big players need to ensure they’re prepared to deploy AI-capable workforces in the coming years.
Inhaled Drug Delivery

Inhaled Biologics: Where Are We Now?

Inhaled biologics are being evaluated as an alternative to injections for treating rare and serious diseases. Experts touch on several challenges including making stable and safe formulations of inhaled biologics.
Drug Formulation

FDA Publishes Paper Asking Manufacturers for Feedback on AI and Regulation

Key regulatory considerations for the application of AI to pharmaceutical manufacturing were outlined by the Center for Drug Evaluation and Research.
Drug Formulation

Three Ways AI and Machine Learning Will Enhance Drug Discovery and Drug Candidate Identification

Here, we explore three emerging technologies and the ways in which they’re helping to revolutionise the development of drugs, such as treatments for COVID-19, cancer research, and dementia.
Drug Formulation

“Stability Can be a Problem” — Dealing with Nanoparticle Stability Challenges in Drug Formulation

Cholesterol oxidation, working with regulators, drug loading nanoparticles, and functional excipients for specific pathways.
Drug Formulation

Long-Acting Injectables: Machine Learning in Drug Formulation and Therapeutic Development

Machine learning approaches may help to accelerate the formulation process for long-acting injectables, improving treatment options and therapeutic availability for patients.
Drug Formulation

How Can AI/ML Approaches Help Move Small Molecule Compounds Towards Regulatory Approval?

Incorporating AI/ML approaches into the holistic identification lifecycle can help to improve the efficiency of a compound reaching the next stage of validation, streamlining the initial identification process.
Drug Formulation

Cipla Stock Falls After 8 Observations from GMP Inspection

The Indian pharma giant comes out of inspection with eight observations in its generic manufacturing plant.
Drug Delivery

Study Finds FDA 510(k) Approval Loophole Linked to Class I Recalls for Medical Devices

The study found that faulty medical devices with potentially compromising shortcomings may still be valid as blueprints for future products, with more Class I recall events seen in 2022.
Drug Formulation

Celadon’s Medicinal Cannabis Facility Awarded GMP Registration by MHRA

The medicinal cannabis manufacturer Celadon Pharmaceuticals has had its facility in the Midlands registered as GMP by MHRA.
Drug Formulation

CROs, Strategy, and Sustainable Testing: Navigating Formulation Development for Biologics

An expert panel of formulation scientists discuss the challenges and solutions within the formulation development for biologics.
Drug Delivery

Examining New Technologies for the Delivery of Therapeutics

Our discussion group on new delivery technologies considered novel and imaginative techniques for delivering drugs to their active sites.
Drug Delivery

Innovative Approaches to Nano Delivery

Key opinion leaders from AstraZeneca and King’s College London present their findings on cutting-edge approaches to nano delivery.
Drug Delivery

Controlled Drug Delivery of Oral Liquid Dosage Forms

Liquid formulations of medicines exist to serve the needs of vulnerable patients. What are their applications? And what challenges are they facing, both in industry and on the market?
Inhaled Drug Delivery

Experts Investigate the Process and Formulation of Dry Powder Inhaled Drugs

Our Inhaled Therapeutics discussion group brought together key experts in the field of dry powder formulation to discuss their research into both formulation and process.
Drug Formulation

Leveraging In-Silico Tools for Optimised Process Development

Karsten Flügel of Merck Healthcare discusses how in-silico tools are used to optimise process development for drug production.
Inhaled Drug Delivery

Optimising Patient Centric Design for Inhaled Products

Our expert panel discuss the process of ensuring that inhalation devices are not burdensome to use.

Oxford Global's R&D Key 40 Stories 2022

Download a copy of the R&D Key 40 Stories 2022 eBook today.
Inhaled Drug Delivery

Patient First: The Necessity of Patient-Centric Product Design for Enhanced Pulmonary Drug Delivery

When designing drug-delivery devices, the patient must be at the centre of the development process. Nélio Drumond of Takeda Pharmaceuticals discusses how this patient-centric approach allows the design to maximise efficiency and efficacy.
Drug Formulation

Experts Discuss the Particular Challenges of Biotherapeutic Formulation Development

Our Formulation discussion group this September focused on the unique challenges of developing formulations for biotherapeutics
Drug Formulation

Challenges in the Formulation of Biologics: Protein Aggregation, Safety, and Technology

Our panel discussion from Formulation UK 2021 highlights protein aggregation, safety, and novel technologies.
Drug Delivery

Evaluating Closed System Drug-Transfer Devices

Using a combination of prevalent CSTDs with biologic molecules, we present a systematic approach to evaluate the risks and impact of CSTD to drug product quality, dose preparation, and dosing accuracy
RNA Formulation & Delivery

From LNPs to AAVs: Overcoming RNA Delivery Challenges

RNA therapeutics have great potential, as evidenced by the success of Pfizer-BioNTech and Moderna’s COVID vaccines. One difficulty that may stunt their success lies in their delivery challenges.
Drug Delivery

Key Strategies and Challenges for Lipid Nanoparticles

June’s Formulation discussion group focusses on nanoparticle development, safety, and optimisation.
Drug Delivery

“Teaching Old Drugs New Tricks”: Repurposing Therapies Using Nanoparticle Delivery

Tackling problems in cancer resistance by turning to using already approved drugs in new ways.
Drug Delivery

Exploring Ways of Crossing the Blood-Brain Barrier

The blood-brain barrier is one of the greatest challenges in drug delivery. The complex issue of getting active molecules out of the blood and into the brain is a task that requires innovative solutions. We discuss some of those methods here.
Drug Delivery

Handle with Care: Continuous Delivery of Fragile Molecules

Peptides and proteins present unique challenges in long-acting sustained drug delivery. How is MedinCell innovating within this field to achieve a customisable platform for long-acting injectable delivery?
RNA Formulation & Delivery

The Past 20 Years of RNA Therapeutics: COVID Vaccines and Beyond

Antonin de Fougerolles explains the development of LNPs which was fundamental in enabling COVID mRNA vaccines. Dr. de Fougerolles also talks on novel delivery methods such as GalNAc conjugates and exosomes.
Inhaled Drug Delivery

Inhalation and Nasal Development and Manufacturing Services

Recipharm offers inhalation and nasal product development services in compliance with regulatory guidelines from the ICH, EMA and FDA.
RNA Formulation & Delivery

Embracing The Power of RNA Therapeutics

Despite initial scepticism, RNA therapeutics have proven to be effective for a wide range of diseases and conditions. We are still in a pivotal era of the field, with many new and exciting research projects underway to discover novel applications.
Inhaled Drug Delivery

How Are Inhaled Drugs Absorbed and Distributed in the Lungs?

Inhaled drugs are a viable means of targeting tobacco smoke-related diseases in the lungs: permeability is key to their successful delivery. This Commentary article explores the mechanisms by which drugs are delivered across cell membranes, as well as pertinent areas for present and future research.
Bioanalysis

Bioanalysis: Predicting Protein Aggregation & Method Validation

Bioanalysis is an important tool to predict the stability and protein degradation in new pharmaceutical products. Can novel prediction methods provide an alternative to current methods?
Bioanalysis

Key Insights: Scaling Up Pharmaceutical Lyophilization Processes

This month the group addressed challenges for lyophilization scale up. The group was led by Claudia Krichbaum, Principal Scientist, Pharmaceutical Technologies, at Merck Healthcare KGaA.
RNA Formulation & Delivery

mRNA Manufacturing: Scalability and Process Analytical Techniques

mRNA delivery techniques took a long time to come to fruition, but recent advancements have enabled production at a scale never seen before.
Drug Formulation

Analytical and Materials Science Solutions

Supporting pharmaceutical and consumer healthcare with development, validation, and application of testing methods.
Drug Delivery

Combination Products: Navigating Recent Regulatory Changes

Despite their advantages, combination products present new technological and organizational challenges. They require new product development strategies compared to standalone products, drugs, and devices.
Drug Formulation

Crystal16: The New Industry Standard

Crystal16 product sheet
Drug Formulation

Crystalline: Seeing is Believing

Access crystallization and formulation information at mL scale with the Crystalline series
Drug Formulation

Managing Complexity to Enhance Life

MUNIT is the world leading player in the field of particle size engineering for pharmaceutical substances, offering tailored solutions to enhance the physical behaviour of drug molecules.
Drug Formulation

Merck KGaA Application Services

Wide-ranging solutions. Unrivalled support
Drug Formulation

Merck KGaA: GMP Manufacturing Capabilities

Commercial Contract Manufacturing | Clinical Supply
Drug Formulation

Merck KGaA: Granulated Materials

Easy handling for improved process efficiency
Drug Formulation

Process Chemicals for RNA Drug Manufacturing

Providing high quality raw materials and services for mRNA manufacturing and formulation
Drug Formulation

Satisfy Your Regulatory Requirements

Transparency and comprehensive documentation with the Emprove® Program
Drug Formulation

tesa: By Your Side From Idea to Market

We Are Your Full Service CDMO for Transdermal Patches and Oral Films
Drug Formulation

Continuous Manufacturing: Challenges & Solutions

While new manufacturing technologies have the potentially to dramatically shift the way the pharmaceutical industry works, many challenges are preventing wider adoption.
Drug Delivery

Wicked Problems Need Wicked Solutions: Success Factors for Connected Drug Delivery

Wicked problems – chronic health issues such as diabetes, obesity, and endocrine disorders – are projected to affect close to one billion people worldwide by 2045. By planning ahead and investing in digital healthcare solutions for connected drug delivery, companies such as Novo Nordisk are aiming to meet rising demands for the provision of healthcare as they occur.
Drug Formulation

API Particle Properties and the Importance of Crystallisation Technology

In this commentary article, we present Axel Becker's insights on the latest techniques governing API particle properties and the processes that dictate the success of drug reception and tablet compression.
Inhaled Drug Delivery

Inhalation Products: Addressing Unmet Needs

This month, the discussion group debated the advantages and disadvantages of different types of inhalers. One key area of interest was current-day challenges with aerosol delivery, which could be addressed through smart inhalers and other innovative new devices.
Drug Formulation

A Look at New Process Development Techniques

How do we make the most of new techniques to optimise product development?
RNA Formulation & Delivery

Prominent Names in RNA Delivery Discuss What’s Around the Corner

Beyond the blood–brain barrier, the pulmonary power of nebulisers, and RNA science in the post-COVID era
Drug Formulation

Accelerating Drug Development with Continuous Manufacturing

The pharmaceutical industry has historically taken a cautious approach to most new advancements, but now it is embracing the possibilities of continuous manufacturing technologies. While traditional batch-based processes are still more common, there are several products on the market that have utilized continuous manufacturing practices.
RNA Formulation & Delivery

A New Frontier: RNA-Based Vaccines & Cancer Treatments

RNA based therapeutics, particularly mRNA, has been experiencing a period of rapid growth, partly due to the influx of funding for mRNA Covid-19 Vaccines. One area that has the potential to benefit from mRNA vaccines is cancer. There are various techniques that have potential to combat the deadly disease.   
RNA Formulation & Delivery

Market Trends and Challenges: RNA Therapeutics & Delivery US: Online

This event brought over 600 leading industry minds together to discuss the latest crucial developments in RNA based therapeutics, from mRNA in vaccine development through to microRNA, siRNA, as well as antisense and RNA interference. RNA Therapeutics & Delivery US: Online featured two days of cutting-edge exhibitions and knowledge sharing, consisting of over 30 presentations, roundtables, panel discussions and ask-the-expert Q&As taking place across both days of the event. 

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things formulation & delivery